Global MRD (Minimal Residual Disease) Testing Market Research Report 2024(Status and Outlook)
Report Overview
Minimal residual disease (MRD) refers to the small number of cancer cells that remain in the body after treatment. The number of remaining cells may be so small that they do not cause any physical signs or symptoms and often cannot even be detected through traditional methods, such as viewing cells under a microscope and/or by tracking abnormal serum proteins in the blood. An MRD positive test result means that residual (remaining) disease was detected. A negative result means that residual disease was not detected,The most widely used tests to measure MRD are flow cytometry, polymerase chain reaction (PCR) and next-generation sequencing (NGS).
This report provides a deep insight into the global MRD (Minimal Residual Disease) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global MRD (Minimal Residual Disease) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the MRD (Minimal Residual Disease) Testing market in any manner.
Global MRD (Minimal Residual Disease) Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ICON plc
ArcherDX(Invitae)
ARUP Laboratories
Asuragen
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
LabCorp
Inivata
Natera
NeoGenomics Laboratories
Opko Health
Quest Diagnostics
Sysmex Corporation
Adaptive Biotechnologies
Market Segmentation (by Type)
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Market Segmentation (by Application)
Specialty Clinics and Hospitals
Diagnostic Laboratories
Research Institutions
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the MRD (Minimal Residual Disease) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Minimal residual disease (MRD) refers to the small number of cancer cells that remain in the body after treatment. The number of remaining cells may be so small that they do not cause any physical signs or symptoms and often cannot even be detected through traditional methods, such as viewing cells under a microscope and/or by tracking abnormal serum proteins in the blood. An MRD positive test result means that residual (remaining) disease was detected. A negative result means that residual disease was not detected,The most widely used tests to measure MRD are flow cytometry, polymerase chain reaction (PCR) and next-generation sequencing (NGS).
This report provides a deep insight into the global MRD (Minimal Residual Disease) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global MRD (Minimal Residual Disease) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the MRD (Minimal Residual Disease) Testing market in any manner.
Global MRD (Minimal Residual Disease) Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ICON plc
ArcherDX(Invitae)
ARUP Laboratories
Asuragen
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
LabCorp
Inivata
Natera
NeoGenomics Laboratories
Opko Health
Quest Diagnostics
Sysmex Corporation
Adaptive Biotechnologies
Market Segmentation (by Type)
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Market Segmentation (by Application)
Specialty Clinics and Hospitals
Diagnostic Laboratories
Research Institutions
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the MRD (Minimal Residual Disease) Testing Market
- Overview of the regional outlook of the MRD (Minimal Residual Disease) Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the MRD (Minimal Residual Disease) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of MRD (Minimal Residual Disease) Testing
1.2 Key Market Segments
1.2.1 MRD (Minimal Residual Disease) Testing Segment by Type
1.2.2 MRD (Minimal Residual Disease) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global MRD (Minimal Residual Disease) Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global MRD (Minimal Residual Disease) Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global MRD (Minimal Residual Disease) Testing Sales by Manufacturers (2019-2024)
3.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global MRD (Minimal Residual Disease) Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers MRD (Minimal Residual Disease) Testing Sales Sites, Area Served, Product Type
3.6 MRD (Minimal Residual Disease) Testing Market Competitive Situation and Trends
3.6.1 MRD (Minimal Residual Disease) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest MRD (Minimal Residual Disease) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MRD (MINIMAL RESIDUAL DISEASE) TESTING INDUSTRY CHAIN ANALYSIS
4.1 MRD (Minimal Residual Disease) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2019-2024)
6.3 Global MRD (Minimal Residual Disease) Testing Market Size Market Share by Type (2019-2024)
6.4 Global MRD (Minimal Residual Disease) Testing Price by Type (2019-2024)
7 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global MRD (Minimal Residual Disease) Testing Market Sales by Application (2019-2024)
7.3 Global MRD (Minimal Residual Disease) Testing Market Size (M USD) by Application (2019-2024)
7.4 Global MRD (Minimal Residual Disease) Testing Sales Growth Rate by Application (2019-2024)
8 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET SEGMENTATION BY REGION
8.1 Global MRD (Minimal Residual Disease) Testing Sales by Region
8.1.1 Global MRD (Minimal Residual Disease) Testing Sales by Region
8.1.2 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America MRD (Minimal Residual Disease) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe MRD (Minimal Residual Disease) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America MRD (Minimal Residual Disease) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ICON plc
9.1.1 ICON plc MRD (Minimal Residual Disease) Testing Basic Information
9.1.2 ICON plc MRD (Minimal Residual Disease) Testing Product Overview
9.1.3 ICON plc MRD (Minimal Residual Disease) Testing Product Market Performance
9.1.4 ICON plc Business Overview
9.1.5 ICON plc MRD (Minimal Residual Disease) Testing SWOT Analysis
9.1.6 ICON plc Recent Developments
9.2 ArcherDX(Invitae)
9.2.1 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Basic Information
9.2.2 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Overview
9.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Market Performance
9.2.4 ArcherDX(Invitae) Business Overview
9.2.5 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing SWOT Analysis
9.2.6 ArcherDX(Invitae) Recent Developments
9.3 ARUP Laboratories
9.3.1 ARUP Laboratories MRD (Minimal Residual Disease) Testing Basic Information
9.3.2 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Overview
9.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Market Performance
9.3.4 ARUP Laboratories MRD (Minimal Residual Disease) Testing SWOT Analysis
9.3.5 ARUP Laboratories Business Overview
9.3.6 ARUP Laboratories Recent Developments
9.4 Asuragen
9.4.1 Asuragen MRD (Minimal Residual Disease) Testing Basic Information
9.4.2 Asuragen MRD (Minimal Residual Disease) Testing Product Overview
9.4.3 Asuragen MRD (Minimal Residual Disease) Testing Product Market Performance
9.4.4 Asuragen Business Overview
9.4.5 Asuragen Recent Developments
9.5 Cergentis B.V.
9.5.1 Cergentis B.V. MRD (Minimal Residual Disease) Testing Basic Information
9.5.2 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Overview
9.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Market Performance
9.5.4 Cergentis B.V. Business Overview
9.5.5 Cergentis B.V. Recent Developments
9.6 Bio-Rad Laboratories
9.6.1 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Basic Information
9.6.2 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Overview
9.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Market Performance
9.6.4 Bio-Rad Laboratories Business Overview
9.6.5 Bio-Rad Laboratories Recent Developments
9.7 Mission Bio
9.7.1 Mission Bio MRD (Minimal Residual Disease) Testing Basic Information
9.7.2 Mission Bio MRD (Minimal Residual Disease) Testing Product Overview
9.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Product Market Performance
9.7.4 Mission Bio Business Overview
9.7.5 Mission Bio Recent Developments
9.8 Guardant Health
9.8.1 Guardant Health MRD (Minimal Residual Disease) Testing Basic Information
9.8.2 Guardant Health MRD (Minimal Residual Disease) Testing Product Overview
9.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Product Market Performance
9.8.4 Guardant Health Business Overview
9.8.5 Guardant Health Recent Developments
9.9 Invivoscribe
9.9.1 Invivoscribe MRD (Minimal Residual Disease) Testing Basic Information
9.9.2 Invivoscribe MRD (Minimal Residual Disease) Testing Product Overview
9.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Product Market Performance
9.9.4 Invivoscribe Business Overview
9.9.5 Invivoscribe Recent Developments
9.10 LabCorp
9.10.1 LabCorp MRD (Minimal Residual Disease) Testing Basic Information
9.10.2 LabCorp MRD (Minimal Residual Disease) Testing Product Overview
9.10.3 LabCorp MRD (Minimal Residual Disease) Testing Product Market Performance
9.10.4 LabCorp Business Overview
9.10.5 LabCorp Recent Developments
9.11 Inivata
9.11.1 Inivata MRD (Minimal Residual Disease) Testing Basic Information
9.11.2 Inivata MRD (Minimal Residual Disease) Testing Product Overview
9.11.3 Inivata MRD (Minimal Residual Disease) Testing Product Market Performance
9.11.4 Inivata Business Overview
9.11.5 Inivata Recent Developments
9.12 Natera
9.12.1 Natera MRD (Minimal Residual Disease) Testing Basic Information
9.12.2 Natera MRD (Minimal Residual Disease) Testing Product Overview
9.12.3 Natera MRD (Minimal Residual Disease) Testing Product Market Performance
9.12.4 Natera Business Overview
9.12.5 Natera Recent Developments
9.13 NeoGenomics Laboratories
9.13.1 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Basic Information
9.13.2 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Overview
9.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Market Performance
9.13.4 NeoGenomics Laboratories Business Overview
9.13.5 NeoGenomics Laboratories Recent Developments
9.14 Opko Health
9.14.1 Opko Health MRD (Minimal Residual Disease) Testing Basic Information
9.14.2 Opko Health MRD (Minimal Residual Disease) Testing Product Overview
9.14.3 Opko Health MRD (Minimal Residual Disease) Testing Product Market Performance
9.14.4 Opko Health Business Overview
9.14.5 Opko Health Recent Developments
9.15 Quest Diagnostics
9.15.1 Quest Diagnostics MRD (Minimal Residual Disease) Testing Basic Information
9.15.2 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Overview
9.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Market Performance
9.15.4 Quest Diagnostics Business Overview
9.15.5 Quest Diagnostics Recent Developments
9.16 Sysmex Corporation
9.16.1 Sysmex Corporation MRD (Minimal Residual Disease) Testing Basic Information
9.16.2 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Overview
9.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Market Performance
9.16.4 Sysmex Corporation Business Overview
9.16.5 Sysmex Corporation Recent Developments
9.17 Adaptive Biotechnologies
9.17.1 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Basic Information
9.17.2 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Overview
9.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Market Performance
9.17.4 Adaptive Biotechnologies Business Overview
9.17.5 Adaptive Biotechnologies Recent Developments
10 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET FORECAST BY REGION
10.1 Global MRD (Minimal Residual Disease) Testing Market Size Forecast
10.2 Global MRD (Minimal Residual Disease) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe MRD (Minimal Residual Disease) Testing Market Size Forecast by Country
10.2.3 Asia Pacific MRD (Minimal Residual Disease) Testing Market Size Forecast by Region
10.2.4 South America MRD (Minimal Residual Disease) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of MRD (Minimal Residual Disease) Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global MRD (Minimal Residual Disease) Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of MRD (Minimal Residual Disease) Testing by Type (2025-2030)
11.1.2 Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of MRD (Minimal Residual Disease) Testing by Type (2025-2030)
11.2 Global MRD (Minimal Residual Disease) Testing Market Forecast by Application (2025-2030)
11.2.1 Global MRD (Minimal Residual Disease) Testing Sales (K Units) Forecast by Application
11.2.2 Global MRD (Minimal Residual Disease) Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of MRD (Minimal Residual Disease) Testing
1.2 Key Market Segments
1.2.1 MRD (Minimal Residual Disease) Testing Segment by Type
1.2.2 MRD (Minimal Residual Disease) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global MRD (Minimal Residual Disease) Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global MRD (Minimal Residual Disease) Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global MRD (Minimal Residual Disease) Testing Sales by Manufacturers (2019-2024)
3.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global MRD (Minimal Residual Disease) Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers MRD (Minimal Residual Disease) Testing Sales Sites, Area Served, Product Type
3.6 MRD (Minimal Residual Disease) Testing Market Competitive Situation and Trends
3.6.1 MRD (Minimal Residual Disease) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest MRD (Minimal Residual Disease) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MRD (MINIMAL RESIDUAL DISEASE) TESTING INDUSTRY CHAIN ANALYSIS
4.1 MRD (Minimal Residual Disease) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2019-2024)
6.3 Global MRD (Minimal Residual Disease) Testing Market Size Market Share by Type (2019-2024)
6.4 Global MRD (Minimal Residual Disease) Testing Price by Type (2019-2024)
7 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global MRD (Minimal Residual Disease) Testing Market Sales by Application (2019-2024)
7.3 Global MRD (Minimal Residual Disease) Testing Market Size (M USD) by Application (2019-2024)
7.4 Global MRD (Minimal Residual Disease) Testing Sales Growth Rate by Application (2019-2024)
8 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET SEGMENTATION BY REGION
8.1 Global MRD (Minimal Residual Disease) Testing Sales by Region
8.1.1 Global MRD (Minimal Residual Disease) Testing Sales by Region
8.1.2 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America MRD (Minimal Residual Disease) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe MRD (Minimal Residual Disease) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America MRD (Minimal Residual Disease) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ICON plc
9.1.1 ICON plc MRD (Minimal Residual Disease) Testing Basic Information
9.1.2 ICON plc MRD (Minimal Residual Disease) Testing Product Overview
9.1.3 ICON plc MRD (Minimal Residual Disease) Testing Product Market Performance
9.1.4 ICON plc Business Overview
9.1.5 ICON plc MRD (Minimal Residual Disease) Testing SWOT Analysis
9.1.6 ICON plc Recent Developments
9.2 ArcherDX(Invitae)
9.2.1 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Basic Information
9.2.2 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Overview
9.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Market Performance
9.2.4 ArcherDX(Invitae) Business Overview
9.2.5 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing SWOT Analysis
9.2.6 ArcherDX(Invitae) Recent Developments
9.3 ARUP Laboratories
9.3.1 ARUP Laboratories MRD (Minimal Residual Disease) Testing Basic Information
9.3.2 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Overview
9.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Market Performance
9.3.4 ARUP Laboratories MRD (Minimal Residual Disease) Testing SWOT Analysis
9.3.5 ARUP Laboratories Business Overview
9.3.6 ARUP Laboratories Recent Developments
9.4 Asuragen
9.4.1 Asuragen MRD (Minimal Residual Disease) Testing Basic Information
9.4.2 Asuragen MRD (Minimal Residual Disease) Testing Product Overview
9.4.3 Asuragen MRD (Minimal Residual Disease) Testing Product Market Performance
9.4.4 Asuragen Business Overview
9.4.5 Asuragen Recent Developments
9.5 Cergentis B.V.
9.5.1 Cergentis B.V. MRD (Minimal Residual Disease) Testing Basic Information
9.5.2 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Overview
9.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Market Performance
9.5.4 Cergentis B.V. Business Overview
9.5.5 Cergentis B.V. Recent Developments
9.6 Bio-Rad Laboratories
9.6.1 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Basic Information
9.6.2 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Overview
9.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Market Performance
9.6.4 Bio-Rad Laboratories Business Overview
9.6.5 Bio-Rad Laboratories Recent Developments
9.7 Mission Bio
9.7.1 Mission Bio MRD (Minimal Residual Disease) Testing Basic Information
9.7.2 Mission Bio MRD (Minimal Residual Disease) Testing Product Overview
9.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Product Market Performance
9.7.4 Mission Bio Business Overview
9.7.5 Mission Bio Recent Developments
9.8 Guardant Health
9.8.1 Guardant Health MRD (Minimal Residual Disease) Testing Basic Information
9.8.2 Guardant Health MRD (Minimal Residual Disease) Testing Product Overview
9.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Product Market Performance
9.8.4 Guardant Health Business Overview
9.8.5 Guardant Health Recent Developments
9.9 Invivoscribe
9.9.1 Invivoscribe MRD (Minimal Residual Disease) Testing Basic Information
9.9.2 Invivoscribe MRD (Minimal Residual Disease) Testing Product Overview
9.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Product Market Performance
9.9.4 Invivoscribe Business Overview
9.9.5 Invivoscribe Recent Developments
9.10 LabCorp
9.10.1 LabCorp MRD (Minimal Residual Disease) Testing Basic Information
9.10.2 LabCorp MRD (Minimal Residual Disease) Testing Product Overview
9.10.3 LabCorp MRD (Minimal Residual Disease) Testing Product Market Performance
9.10.4 LabCorp Business Overview
9.10.5 LabCorp Recent Developments
9.11 Inivata
9.11.1 Inivata MRD (Minimal Residual Disease) Testing Basic Information
9.11.2 Inivata MRD (Minimal Residual Disease) Testing Product Overview
9.11.3 Inivata MRD (Minimal Residual Disease) Testing Product Market Performance
9.11.4 Inivata Business Overview
9.11.5 Inivata Recent Developments
9.12 Natera
9.12.1 Natera MRD (Minimal Residual Disease) Testing Basic Information
9.12.2 Natera MRD (Minimal Residual Disease) Testing Product Overview
9.12.3 Natera MRD (Minimal Residual Disease) Testing Product Market Performance
9.12.4 Natera Business Overview
9.12.5 Natera Recent Developments
9.13 NeoGenomics Laboratories
9.13.1 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Basic Information
9.13.2 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Overview
9.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Market Performance
9.13.4 NeoGenomics Laboratories Business Overview
9.13.5 NeoGenomics Laboratories Recent Developments
9.14 Opko Health
9.14.1 Opko Health MRD (Minimal Residual Disease) Testing Basic Information
9.14.2 Opko Health MRD (Minimal Residual Disease) Testing Product Overview
9.14.3 Opko Health MRD (Minimal Residual Disease) Testing Product Market Performance
9.14.4 Opko Health Business Overview
9.14.5 Opko Health Recent Developments
9.15 Quest Diagnostics
9.15.1 Quest Diagnostics MRD (Minimal Residual Disease) Testing Basic Information
9.15.2 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Overview
9.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Market Performance
9.15.4 Quest Diagnostics Business Overview
9.15.5 Quest Diagnostics Recent Developments
9.16 Sysmex Corporation
9.16.1 Sysmex Corporation MRD (Minimal Residual Disease) Testing Basic Information
9.16.2 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Overview
9.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Market Performance
9.16.4 Sysmex Corporation Business Overview
9.16.5 Sysmex Corporation Recent Developments
9.17 Adaptive Biotechnologies
9.17.1 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Basic Information
9.17.2 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Overview
9.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Market Performance
9.17.4 Adaptive Biotechnologies Business Overview
9.17.5 Adaptive Biotechnologies Recent Developments
10 MRD (MINIMAL RESIDUAL DISEASE) TESTING MARKET FORECAST BY REGION
10.1 Global MRD (Minimal Residual Disease) Testing Market Size Forecast
10.2 Global MRD (Minimal Residual Disease) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe MRD (Minimal Residual Disease) Testing Market Size Forecast by Country
10.2.3 Asia Pacific MRD (Minimal Residual Disease) Testing Market Size Forecast by Region
10.2.4 South America MRD (Minimal Residual Disease) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of MRD (Minimal Residual Disease) Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global MRD (Minimal Residual Disease) Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of MRD (Minimal Residual Disease) Testing by Type (2025-2030)
11.1.2 Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of MRD (Minimal Residual Disease) Testing by Type (2025-2030)
11.2 Global MRD (Minimal Residual Disease) Testing Market Forecast by Application (2025-2030)
11.2.1 Global MRD (Minimal Residual Disease) Testing Sales (K Units) Forecast by Application
11.2.2 Global MRD (Minimal Residual Disease) Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. MRD (Minimal Residual Disease) Testing Market Size Comparison by Region (M USD)
Table 5. Global MRD (Minimal Residual Disease) Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global MRD (Minimal Residual Disease) Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global MRD (Minimal Residual Disease) Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MRD (Minimal Residual Disease) Testing as of 2022)
Table 10. Global Market MRD (Minimal Residual Disease) Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers MRD (Minimal Residual Disease) Testing Sales Sites and Area Served
Table 12. Manufacturers MRD (Minimal Residual Disease) Testing Product Type
Table 13. Global MRD (Minimal Residual Disease) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of MRD (Minimal Residual Disease) Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. MRD (Minimal Residual Disease) Testing Market Challenges
Table 22. Global MRD (Minimal Residual Disease) Testing Sales by Type (K Units)
Table 23. Global MRD (Minimal Residual Disease) Testing Market Size by Type (M USD)
Table 24. Global MRD (Minimal Residual Disease) Testing Sales (K Units) by Type (2019-2024)
Table 25. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2019-2024)
Table 26. Global MRD (Minimal Residual Disease) Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global MRD (Minimal Residual Disease) Testing Market Size Share by Type (2019-2024)
Table 28. Global MRD (Minimal Residual Disease) Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global MRD (Minimal Residual Disease) Testing Sales (K Units) by Application
Table 30. Global MRD (Minimal Residual Disease) Testing Market Size by Application
Table 31. Global MRD (Minimal Residual Disease) Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2019-2024)
Table 33. Global MRD (Minimal Residual Disease) Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global MRD (Minimal Residual Disease) Testing Market Share by Application (2019-2024)
Table 35. Global MRD (Minimal Residual Disease) Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global MRD (Minimal Residual Disease) Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2019-2024)
Table 38. North America MRD (Minimal Residual Disease) Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America MRD (Minimal Residual Disease) Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Region (2019-2024) & (K Units)
Table 43. ICON plc MRD (Minimal Residual Disease) Testing Basic Information
Table 44. ICON plc MRD (Minimal Residual Disease) Testing Product Overview
Table 45. ICON plc MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. ICON plc Business Overview
Table 47. ICON plc MRD (Minimal Residual Disease) Testing SWOT Analysis
Table 48. ICON plc Recent Developments
Table 49. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Basic Information
Table 50. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Overview
Table 51. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. ArcherDX(Invitae) Business Overview
Table 53. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing SWOT Analysis
Table 54. ArcherDX(Invitae) Recent Developments
Table 55. ARUP Laboratories MRD (Minimal Residual Disease) Testing Basic Information
Table 56. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Overview
Table 57. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. ARUP Laboratories MRD (Minimal Residual Disease) Testing SWOT Analysis
Table 59. ARUP Laboratories Business Overview
Table 60. ARUP Laboratories Recent Developments
Table 61. Asuragen MRD (Minimal Residual Disease) Testing Basic Information
Table 62. Asuragen MRD (Minimal Residual Disease) Testing Product Overview
Table 63. Asuragen MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Asuragen Business Overview
Table 65. Asuragen Recent Developments
Table 66. Cergentis B.V. MRD (Minimal Residual Disease) Testing Basic Information
Table 67. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Overview
Table 68. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cergentis B.V. Business Overview
Table 70. Cergentis B.V. Recent Developments
Table 71. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Basic Information
Table 72. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Overview
Table 73. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Bio-Rad Laboratories Business Overview
Table 75. Bio-Rad Laboratories Recent Developments
Table 76. Mission Bio MRD (Minimal Residual Disease) Testing Basic Information
Table 77. Mission Bio MRD (Minimal Residual Disease) Testing Product Overview
Table 78. Mission Bio MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Mission Bio Business Overview
Table 80. Mission Bio Recent Developments
Table 81. Guardant Health MRD (Minimal Residual Disease) Testing Basic Information
Table 82. Guardant Health MRD (Minimal Residual Disease) Testing Product Overview
Table 83. Guardant Health MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Guardant Health Business Overview
Table 85. Guardant Health Recent Developments
Table 86. Invivoscribe MRD (Minimal Residual Disease) Testing Basic Information
Table 87. Invivoscribe MRD (Minimal Residual Disease) Testing Product Overview
Table 88. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Invivoscribe Business Overview
Table 90. Invivoscribe Recent Developments
Table 91. LabCorp MRD (Minimal Residual Disease) Testing Basic Information
Table 92. LabCorp MRD (Minimal Residual Disease) Testing Product Overview
Table 93. LabCorp MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. LabCorp Business Overview
Table 95. LabCorp Recent Developments
Table 96. Inivata MRD (Minimal Residual Disease) Testing Basic Information
Table 97. Inivata MRD (Minimal Residual Disease) Testing Product Overview
Table 98. Inivata MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Inivata Business Overview
Table 100. Inivata Recent Developments
Table 101. Natera MRD (Minimal Residual Disease) Testing Basic Information
Table 102. Natera MRD (Minimal Residual Disease) Testing Product Overview
Table 103. Natera MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Natera Business Overview
Table 105. Natera Recent Developments
Table 106. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Basic Information
Table 107. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Overview
Table 108. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. NeoGenomics Laboratories Business Overview
Table 110. NeoGenomics Laboratories Recent Developments
Table 111. Opko Health MRD (Minimal Residual Disease) Testing Basic Information
Table 112. Opko Health MRD (Minimal Residual Disease) Testing Product Overview
Table 113. Opko Health MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Opko Health Business Overview
Table 115. Opko Health Recent Developments
Table 116. Quest Diagnostics MRD (Minimal Residual Disease) Testing Basic Information
Table 117. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Overview
Table 118. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Quest Diagnostics Business Overview
Table 120. Quest Diagnostics Recent Developments
Table 121. Sysmex Corporation MRD (Minimal Residual Disease) Testing Basic Information
Table 122. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Overview
Table 123. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Sysmex Corporation Business Overview
Table 125. Sysmex Corporation Recent Developments
Table 126. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Basic Information
Table 127. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Overview
Table 128. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Adaptive Biotechnologies Business Overview
Table 130. Adaptive Biotechnologies Recent Developments
Table 131. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America MRD (Minimal Residual Disease) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe MRD (Minimal Residual Disease) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific MRD (Minimal Residual Disease) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America MRD (Minimal Residual Disease) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa MRD (Minimal Residual Disease) Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa MRD (Minimal Residual Disease) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global MRD (Minimal Residual Disease) Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global MRD (Minimal Residual Disease) Testing Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. MRD (Minimal Residual Disease) Testing Market Size Comparison by Region (M USD)
Table 5. Global MRD (Minimal Residual Disease) Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global MRD (Minimal Residual Disease) Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global MRD (Minimal Residual Disease) Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MRD (Minimal Residual Disease) Testing as of 2022)
Table 10. Global Market MRD (Minimal Residual Disease) Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers MRD (Minimal Residual Disease) Testing Sales Sites and Area Served
Table 12. Manufacturers MRD (Minimal Residual Disease) Testing Product Type
Table 13. Global MRD (Minimal Residual Disease) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of MRD (Minimal Residual Disease) Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. MRD (Minimal Residual Disease) Testing Market Challenges
Table 22. Global MRD (Minimal Residual Disease) Testing Sales by Type (K Units)
Table 23. Global MRD (Minimal Residual Disease) Testing Market Size by Type (M USD)
Table 24. Global MRD (Minimal Residual Disease) Testing Sales (K Units) by Type (2019-2024)
Table 25. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2019-2024)
Table 26. Global MRD (Minimal Residual Disease) Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global MRD (Minimal Residual Disease) Testing Market Size Share by Type (2019-2024)
Table 28. Global MRD (Minimal Residual Disease) Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global MRD (Minimal Residual Disease) Testing Sales (K Units) by Application
Table 30. Global MRD (Minimal Residual Disease) Testing Market Size by Application
Table 31. Global MRD (Minimal Residual Disease) Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2019-2024)
Table 33. Global MRD (Minimal Residual Disease) Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global MRD (Minimal Residual Disease) Testing Market Share by Application (2019-2024)
Table 35. Global MRD (Minimal Residual Disease) Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global MRD (Minimal Residual Disease) Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2019-2024)
Table 38. North America MRD (Minimal Residual Disease) Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America MRD (Minimal Residual Disease) Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Region (2019-2024) & (K Units)
Table 43. ICON plc MRD (Minimal Residual Disease) Testing Basic Information
Table 44. ICON plc MRD (Minimal Residual Disease) Testing Product Overview
Table 45. ICON plc MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. ICON plc Business Overview
Table 47. ICON plc MRD (Minimal Residual Disease) Testing SWOT Analysis
Table 48. ICON plc Recent Developments
Table 49. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Basic Information
Table 50. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Overview
Table 51. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. ArcherDX(Invitae) Business Overview
Table 53. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing SWOT Analysis
Table 54. ArcherDX(Invitae) Recent Developments
Table 55. ARUP Laboratories MRD (Minimal Residual Disease) Testing Basic Information
Table 56. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Overview
Table 57. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. ARUP Laboratories MRD (Minimal Residual Disease) Testing SWOT Analysis
Table 59. ARUP Laboratories Business Overview
Table 60. ARUP Laboratories Recent Developments
Table 61. Asuragen MRD (Minimal Residual Disease) Testing Basic Information
Table 62. Asuragen MRD (Minimal Residual Disease) Testing Product Overview
Table 63. Asuragen MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Asuragen Business Overview
Table 65. Asuragen Recent Developments
Table 66. Cergentis B.V. MRD (Minimal Residual Disease) Testing Basic Information
Table 67. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Overview
Table 68. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cergentis B.V. Business Overview
Table 70. Cergentis B.V. Recent Developments
Table 71. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Basic Information
Table 72. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Overview
Table 73. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Bio-Rad Laboratories Business Overview
Table 75. Bio-Rad Laboratories Recent Developments
Table 76. Mission Bio MRD (Minimal Residual Disease) Testing Basic Information
Table 77. Mission Bio MRD (Minimal Residual Disease) Testing Product Overview
Table 78. Mission Bio MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Mission Bio Business Overview
Table 80. Mission Bio Recent Developments
Table 81. Guardant Health MRD (Minimal Residual Disease) Testing Basic Information
Table 82. Guardant Health MRD (Minimal Residual Disease) Testing Product Overview
Table 83. Guardant Health MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Guardant Health Business Overview
Table 85. Guardant Health Recent Developments
Table 86. Invivoscribe MRD (Minimal Residual Disease) Testing Basic Information
Table 87. Invivoscribe MRD (Minimal Residual Disease) Testing Product Overview
Table 88. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Invivoscribe Business Overview
Table 90. Invivoscribe Recent Developments
Table 91. LabCorp MRD (Minimal Residual Disease) Testing Basic Information
Table 92. LabCorp MRD (Minimal Residual Disease) Testing Product Overview
Table 93. LabCorp MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. LabCorp Business Overview
Table 95. LabCorp Recent Developments
Table 96. Inivata MRD (Minimal Residual Disease) Testing Basic Information
Table 97. Inivata MRD (Minimal Residual Disease) Testing Product Overview
Table 98. Inivata MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Inivata Business Overview
Table 100. Inivata Recent Developments
Table 101. Natera MRD (Minimal Residual Disease) Testing Basic Information
Table 102. Natera MRD (Minimal Residual Disease) Testing Product Overview
Table 103. Natera MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Natera Business Overview
Table 105. Natera Recent Developments
Table 106. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Basic Information
Table 107. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Overview
Table 108. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. NeoGenomics Laboratories Business Overview
Table 110. NeoGenomics Laboratories Recent Developments
Table 111. Opko Health MRD (Minimal Residual Disease) Testing Basic Information
Table 112. Opko Health MRD (Minimal Residual Disease) Testing Product Overview
Table 113. Opko Health MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Opko Health Business Overview
Table 115. Opko Health Recent Developments
Table 116. Quest Diagnostics MRD (Minimal Residual Disease) Testing Basic Information
Table 117. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Overview
Table 118. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Quest Diagnostics Business Overview
Table 120. Quest Diagnostics Recent Developments
Table 121. Sysmex Corporation MRD (Minimal Residual Disease) Testing Basic Information
Table 122. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Overview
Table 123. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Sysmex Corporation Business Overview
Table 125. Sysmex Corporation Recent Developments
Table 126. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Basic Information
Table 127. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Overview
Table 128. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Adaptive Biotechnologies Business Overview
Table 130. Adaptive Biotechnologies Recent Developments
Table 131. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America MRD (Minimal Residual Disease) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe MRD (Minimal Residual Disease) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific MRD (Minimal Residual Disease) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America MRD (Minimal Residual Disease) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa MRD (Minimal Residual Disease) Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa MRD (Minimal Residual Disease) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global MRD (Minimal Residual Disease) Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global MRD (Minimal Residual Disease) Testing Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of MRD (Minimal Residual Disease) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global MRD (Minimal Residual Disease) Testing Market Size (M USD), 2019-2030
Figure 5. Global MRD (Minimal Residual Disease) Testing Market Size (M USD) (2019-2030)
Figure 6. Global MRD (Minimal Residual Disease) Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. MRD (Minimal Residual Disease) Testing Market Size by Country (M USD)
Figure 11. MRD (Minimal Residual Disease) Testing Sales Share by Manufacturers in 2023
Figure 12. Global MRD (Minimal Residual Disease) Testing Revenue Share by Manufacturers in 2023
Figure 13. MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market MRD (Minimal Residual Disease) Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by MRD (Minimal Residual Disease) Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global MRD (Minimal Residual Disease) Testing Market Share by Type
Figure 18. Sales Market Share of MRD (Minimal Residual Disease) Testing by Type (2019-2024)
Figure 19. Sales Market Share of MRD (Minimal Residual Disease) Testing by Type in 2023
Figure 20. Market Size Share of MRD (Minimal Residual Disease) Testing by Type (2019-2024)
Figure 21. Market Size Market Share of MRD (Minimal Residual Disease) Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global MRD (Minimal Residual Disease) Testing Market Share by Application
Figure 24. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2019-2024)
Figure 25. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2023
Figure 26. Global MRD (Minimal Residual Disease) Testing Market Share by Application (2019-2024)
Figure 27. Global MRD (Minimal Residual Disease) Testing Market Share by Application in 2023
Figure 28. Global MRD (Minimal Residual Disease) Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2019-2024)
Figure 30. North America MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2023
Figure 32. U.S. MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada MRD (Minimal Residual Disease) Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico MRD (Minimal Residual Disease) Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2023
Figure 37. Germany MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific MRD (Minimal Residual Disease) Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Market Share by Region in 2023
Figure 44. China MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America MRD (Minimal Residual Disease) Testing Sales and Growth Rate (K Units)
Figure 50. South America MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2023
Figure 51. Brazil MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global MRD (Minimal Residual Disease) Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Application (2025-2030)
Figure 66. Global MRD (Minimal Residual Disease) Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of MRD (Minimal Residual Disease) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global MRD (Minimal Residual Disease) Testing Market Size (M USD), 2019-2030
Figure 5. Global MRD (Minimal Residual Disease) Testing Market Size (M USD) (2019-2030)
Figure 6. Global MRD (Minimal Residual Disease) Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. MRD (Minimal Residual Disease) Testing Market Size by Country (M USD)
Figure 11. MRD (Minimal Residual Disease) Testing Sales Share by Manufacturers in 2023
Figure 12. Global MRD (Minimal Residual Disease) Testing Revenue Share by Manufacturers in 2023
Figure 13. MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market MRD (Minimal Residual Disease) Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by MRD (Minimal Residual Disease) Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global MRD (Minimal Residual Disease) Testing Market Share by Type
Figure 18. Sales Market Share of MRD (Minimal Residual Disease) Testing by Type (2019-2024)
Figure 19. Sales Market Share of MRD (Minimal Residual Disease) Testing by Type in 2023
Figure 20. Market Size Share of MRD (Minimal Residual Disease) Testing by Type (2019-2024)
Figure 21. Market Size Market Share of MRD (Minimal Residual Disease) Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global MRD (Minimal Residual Disease) Testing Market Share by Application
Figure 24. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2019-2024)
Figure 25. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2023
Figure 26. Global MRD (Minimal Residual Disease) Testing Market Share by Application (2019-2024)
Figure 27. Global MRD (Minimal Residual Disease) Testing Market Share by Application in 2023
Figure 28. Global MRD (Minimal Residual Disease) Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2019-2024)
Figure 30. North America MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2023
Figure 32. U.S. MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada MRD (Minimal Residual Disease) Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico MRD (Minimal Residual Disease) Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2023
Figure 37. Germany MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific MRD (Minimal Residual Disease) Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Market Share by Region in 2023
Figure 44. China MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America MRD (Minimal Residual Disease) Testing Sales and Growth Rate (K Units)
Figure 50. South America MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2023
Figure 51. Brazil MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa MRD (Minimal Residual Disease) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global MRD (Minimal Residual Disease) Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global MRD (Minimal Residual Disease) Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Application (2025-2030)
Figure 66. Global MRD (Minimal Residual Disease) Testing Market Share Forecast by Application (2025-2030)
